NCT02608216 2025-09-03
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer
University of Pennsylvania
Phase 1 Active not recruiting
Clinical Trials
11 trialsNCT05835570 2025-04-30
Integrin αvβ6-targeted PET in Malignant Tumors
Zhongnan Hospital
Recruiting
NCT06067503 2025-04-22
Biomarkers to Detect Endocrine Therapy Resistance
University of Wisconsin, Madison
Phase 2 Recruiting
NCT04343079 2024-01-23
Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.
University Hospital, Ghent
Phase NA Unknown
NCT03057743 2021-11-18
Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer
Abramson Cancer Center at Penn Medicine
Terminated
NCT05064475 2021-10-01
Correlation Between PET/CT Parameters and Tumor Markers in Recurrent Breast Cancer
Assiut University
Unknown
NCT04882371 2021-05-11
Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer
Istanbul Medeniyet University
Completed
NCT01892540 2020-03-04
PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT03094897 2017-04-13
Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics
Wuxi No. 4 People's Hospital
Phase EARLY_PHASE1 Unknown
NCT02681640 2017-04-06
uPAR PET/CT for Preoperative Staging of Breast Cancer Patients
Rigshospitalet, Denmark
Phase 2 Completed
NCT01569321 2015-04-21
Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study
Assistance Publique Hopitaux De Marseille
Phase NA Terminated